169 related articles for article (PubMed ID: 20482426)
1. Trends in antipsychotic prescribing practices in an urban community mental health clinic.
Monshat K; Carty B; Olver J; Castle D; Bosanac P
Australas Psychiatry; 2010 Jun; 18(3):238-41. PubMed ID: 20482426
[TBL] [Abstract][Full Text] [Related]
2. Risperidone long-acting therapy prescribing patterns and their impact on early discontinuation of treatment in a large Medicaid population.
Boaz TL; Constantine RJ; Robst J; Becker MA; Howe AM
J Clin Psychiatry; 2011 Aug; 72(8):1079-85. PubMed ID: 21034690
[TBL] [Abstract][Full Text] [Related]
3. Explicit review of risperidone long-acting injection prescribing practice.
Wheeler A; Vanderpyl J; Carswell C; Stojkovic M; Robinson E
J Clin Pharm Ther; 2011 Dec; 36(6):651-63. PubMed ID: 22023342
[TBL] [Abstract][Full Text] [Related]
4. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.
Diatta T; Blazejewski S; Portier A; Lignot S; Quesnot A; Moore N; Fourrier-Réglat A
Fundam Clin Pharmacol; 2007 Aug; 21(4):371-8. PubMed ID: 17635175
[TBL] [Abstract][Full Text] [Related]
5. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
6. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
7. National trends in psychotropic medication polypharmacy in office-based psychiatry.
Mojtabai R; Olfson M
Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
[TBL] [Abstract][Full Text] [Related]
8. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
9. Diffusion of a new drug: a comparative analysis of adoption, treatment complexity, and persistence of risperidone long-acting injectable therapy in the Netherlands.
Pechlivanoglou P; Vehof J; van Agthoven M; de Jong-van den Berg LT; Postma MJ
Clin Ther; 2010 Jan; 32(1):108-18. PubMed ID: 20171417
[TBL] [Abstract][Full Text] [Related]
10. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
11. Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns.
Apiquian R; Fresán A; de la Fuente-Sandoval C; Ulloa RE; Nicolini H
BMC Psychiatry; 2004 Apr; 4():12. PubMed ID: 15109398
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of concomitant oral antipsychotic drug use among patients treated with long-acting, intramuscular, antipsychotic medications.
Aggarwal NK; Sernyak MJ; Rosenheck RA
J Clin Psychopharmacol; 2012 Jun; 32(3):323-8. PubMed ID: 22544006
[TBL] [Abstract][Full Text] [Related]
13. Patterns and determinants of antipsychotic prescribing in children and adolescents, 2003-2004.
Aparasu RR; Bhatara V
Curr Med Res Opin; 2007 Jan; 23(1):49-56. PubMed ID: 17257465
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
[TBL] [Abstract][Full Text] [Related]
15. A prospective study on the pattern of medication use for schizophrenia in the outpatient pharmacy department, Hospital Tengku Ampuan Rahimah, Selangor, Malaysia.
Ponto T; Ismail NI; Abdul Majeed AB; Marmaya NH; Zakaria ZA
Methods Find Exp Clin Pharmacol; 2010; 32(6):427-32. PubMed ID: 20852752
[TBL] [Abstract][Full Text] [Related]
16. Prescribing for inpatients with schizophrenia: an international multi-center comparative study.
Bitter I; Chou JC; Ungvari GS; Tang WK; Xiang Z; Iwanami A; Gaszner P
Pharmacopsychiatry; 2003 Jul; 36(4):143-9. PubMed ID: 12905100
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
[TBL] [Abstract][Full Text] [Related]
18. Trends in treatment of newly treated schizophrenia-spectrum disorder patients in Taiwan from 1999 to 2006.
Wu CS; Lin YJ; Feng J
Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):989-96. PubMed ID: 22416032
[TBL] [Abstract][Full Text] [Related]
19. Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years.
Patel MX; Haddad PM; Chaudhry IB; McLoughlin S; Husain N; David AS
J Psychopharmacol; 2010 Oct; 24(10):1473-82. PubMed ID: 19477883
[TBL] [Abstract][Full Text] [Related]
20. Use of first- and second-generation antipsychotic medications in older patients with schizophrenia in Asia (2001-2009).
Xiang YT; Kreyenbuhl J; Dickerson FB; Ungvari GS; Wang CY; Si TM; Lee EH; He YL; Chiu HF; Yang SY; Chong MY; Tan CH; Kua EH; Fujii S; Sim K; Yong MK; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Shinfuku N
Aust N Z J Psychiatry; 2012 Dec; 46(12):1159-64. PubMed ID: 22790175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
